Skip to content
healthcare.dev

HKI

NDC 62106-0625, Atropinum sulphuricum, Benzoicum acidum, Berberis vulgaris, Calcarea carbonica, Colocynthis, Coccus cacti, Lapis albus, Lithium carbonicum, Lycopodium clavatum, Oryctolagus cuniculus kidney, Rubia tinctorum, Sarsaparilla, Urtica urens, liquid, from Seroyal USA.

Product NDC
62106-0625
Status
Listed
Labeler
Seroyal USA
Dosage form
LIQUID
Route
SUBLINGUAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62106-0625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATROPINE SULFATE6 [hp_X]/30mL
  • OYSTER SHELL CALCIUM CARBONATE, CRUDE12 [hp_X]/30mL
  • CITRULLUS COLOCYNTHIS FRUIT PULP6 [hp_X]/30mL
  • LYCOPODIUM CLAVATUM SPORE5 [hp_X]/30mL
  • ORYCTOLAGUS CUNICULUS KIDNEY10 [hp_X]/30mL
  • SARSAPARILLA1 [hp_X]/30mL
  • CALCIUM HEXAFLUOROSILICATE12 [hp_C]/30mL
  • BENZOIC ACID6 [hp_X]/30mL
  • PROTORTONIA CACTI5 [hp_X]/30mL
  • LITHIUM CARBONATE6 [hp_X]/30mL
  • RUBIA TINCTORUM ROOT4 [hp_X]/30mL
  • URTICA URENS1 [hp_X]/30mL
  • BERBERIS VULGARIS ROOT BARK5 [hp_X]/30mL

Pharmacologic classes

Ammonium Ion Binding Activity [MoA]; Anticholinergic [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]; Mood Stabilizer [EPC]; Nitrogen Binding Agent [EPC]

Package NDCNDC-11Package
62106-0625-0621060625001 BOTTLE, GLASS in 1 CARTON (62106-0625-0) / 30 mL in 1 BOTTLE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62106-0625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62106-0625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62106-0625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.